Navigation Links
Pharmaceutical Budget and Staffing: Powerful New Metrics-Based Study
Date:2/7/2008

CHAPEL HILL, N.C., Feb. 7 /PRNewswire/ -- Falling stock prices, devaluing dollar, soaring gas prices, and the slumping real estate market are just a few of the symptoms of the recession hitting the U.S. economy. While a recession will impact all industries, it may have a deeper impact on pharma and biotech companies as they have already been dealing with increasing pricing and regulatory pressures and decreasing numbers of newly approved therapies. Given the current environment, it is imperative for companies to maintain the appropriate mix of budgets and staffing to meet corporate objectives.

The current report, U.S. Pharmaceutical Budget and Staffing Excellence: Benchmarking the Resources Required to Drive Productivity and Growth, can be an invaluable resource allowing pharmaceutical and biotech executives to critically assess key business functions and resources against thirty-six top pharma and biotech companies. The rich metrics contained in this comprehensive report emanate from survey responses from staffing executives at such elite pharmaceutical and biotech companies as Abbott Labs, AstraZeneca, Bristol-Myers Squibb, J&J, Eli Lilly GlaxoSmithKline, Merck, Novartis, Pfizer, Roche and Sanofi-Aventis.

Executive insight across seven critical functional areas, including:

* Marketing Operations

* Marketing Services

* Sales Support

* Managed Care

* State & Government Affairs

* Finance

* Legal and Compliance

Sampling of the key findings harnessed from the report include:

* Marketing Services groups support an average of 7.8 brands with 6.7 FTEs

allocated per brand promoted

* Sales Support groups allocate approximately $460,000, including labor,

overhead and outsourcing, per sales support FTE

* Managed Care groups report an average of 18 FTEs allocated to Customer

Marketing Strategy

* Finance budgets as a percentage of sales average 1.33%


'/>"/>
SOURCE Best Practices, LLC
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Vion Pharmaceuticals Pays Interest on 7.75% Convertible Senior Notes
2. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
3. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
4. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
5. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
8. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
9. Anadys Pharmaceuticals Appoints Steve Worland, Ph.D. as President and Chief Executive Officer
10. Heritage and Ipca Enter Into Strategic Alliance for Generic Pharmaceutical Products
11. Poniard Pharmaceuticals Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... and NEW YORK CITY ... -- As a leading provider of market research reports and ... Worldwide, LLC, indicating that 2015 will be a year of ... For executives operating a stem cell company or cord ... difficult task. You must analyze market conditions, predict industry trends, ...
(Date:4/1/2015)... Earlier this year, A.J. O’Connor Associates ... that represents research-based life science organizations in New Jersey, ... Vice President of Business Development & Executive Coach, attended ... attracted over 750 attendees. , In one of ... cancer survivor shared his moving story of how, almost ...
(Date:4/1/2015)... April 1, 2015 Immunocore ... novel biological drugs to treat cancer, viral infections ... the appointment of Christina Coughlin as ... for providing medical and regulatory leadership to the ... Dr. Coughlin has extensive experience in oncology ...
(Date:3/31/2015)... , March 31, 2015  Biotest Pharmaceuticals Corporation ... pleased to announce the addition of its newest plasma ... 205 Conway, Arkansas . The over ... for business on March 26 th 2015 and ... to eighteen. "This facility represents another ...
Breaking Biology Technology:MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 2MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 3MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 4HR Consulting Firm, A.J. O'Connor Associates Joins BioNJ – The Vibrant 400 Member Strong Life Sciences Industry Association - and Attends its Annual Dinner 2Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 2Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 3Immunocore Appoints Dr. Christina Coughlin as Chief Medical Officer 4Biotest Pharmaceuticals Corporation Announces the Opening of its Newest Plasma Collection Facility in Conway, Arkansas 2
... , , SAN DIEGO, ... announced its financial results for the quarter ended June 30, 2009. For ... $15.3 million, or $0.39 per share, compared with a net loss of ... For the six months ended June 30, 2009, the Company reported a ...
... Group, Inc. ("BioNeutral") (OTC Bulletin Board: BONU), a chemical technology-based Life Science ... Kielbania will appear on WVOX AM,s "In Focus" radio show on Wednesday ... The radio broadcast may be accessed via the Internet at ... Dan Miller , Dr. Miller is a retired school and college ...
... , , SOUTH SAN ... ) today reported financial results for the second quarter ended June 30, ... of 2009 was $3.5 million, with a net loss of $22.9 million, ... April. Loss from operations was $1.9 million for the second quarter and ...
Cached Biology Technology:Neurocrine Biosciences Reports Second Quarter 2009 Results 2Neurocrine Biosciences Reports Second Quarter 2009 Results 3Neurocrine Biosciences Reports Second Quarter 2009 Results 4Neurocrine Biosciences Reports Second Quarter 2009 Results 5Neurocrine Biosciences Reports Second Quarter 2009 Results 6Neurocrine Biosciences Reports Second Quarter 2009 Results 7BioNeutral Group's CEO, Stephen Browand and Chief Scientist, Dr. Andrew Kielbania to Appear on WVOX 1460 AM 'In Focus' Radio Show Hosted by Dr. Dan Miller 2Sunesis Reports Financial Results for the Second Quarter 2009 2Sunesis Reports Financial Results for the Second Quarter 2009 3Sunesis Reports Financial Results for the Second Quarter 2009 4Sunesis Reports Financial Results for the Second Quarter 2009 5Sunesis Reports Financial Results for the Second Quarter 2009 6Sunesis Reports Financial Results for the Second Quarter 2009 7Sunesis Reports Financial Results for the Second Quarter 2009 8Sunesis Reports Financial Results for the Second Quarter 2009 9Sunesis Reports Financial Results for the Second Quarter 2009 10Sunesis Reports Financial Results for the Second Quarter 2009 11
(Date:3/17/2015)... NEW YORK , March 17, 2015 /PRNewswire/ ... , the largest exhibition for service robots ever ... . RoboUniverse takes place on May 11-13, 2015 ... Sponsors and exhibitors for the event include: Acorn ... Motion Control; EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic ...
(Date:3/12/2015)... IriTech, a leading iris based identity management ... Instruments Design Network, announced today that the Chief Minister ... USB MK2120U device during a launching event of Andhra ... The iris scanner is manufactured by U.S. ... India through its Indian partner, Biometronic ...
(Date:3/12/2015)... 2015 Beta Systems today ... access management (IAM) solution for a fixed price ... System,s new IAM package, customers benefit from the ... multiple IAM implementations across different industries. The new ... as any necessary services and consulting. It spans ...
Breaking Biology News(10 mins):MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 2Indian States See IriTech's Scanner Bolstering Efficiency of Authentication for Aadhaar 3Beta Systems Fast Forward IAM Available Now: a Standardized IAM Package at a Fixed Price 2
... people usually don,t die from a heart attack. But the ... succumb to congestive heart failure, the most common cause of ... hope for achieving what the body can,t do: mending broken ... built a scaffold that supports the growth and integration of ...
... -- A microscopic gene may play a gigantic role when ... to one Kansas State University research team. The team ... Disintegrin and Metalloprotease family, or ADAM family, and its role ... is a good guy or a bad guy in breast ...
... against cancerous tumors, radiation therapy often harms healthy tissue as ... of Tel Aviv University,s Department of Biomedical Engineering is developing ... and minimal damage to surrounding tissue. His innovative ... uses heat to kill the tumor cells but leaves ...
Cached Biology News:A strategy to fix a broken heart 2A strategy to fix a broken heart 3K-State research team investigates mutated gene's role in breast cancer 2A 'magnetic' solution to identify and kill tumors 2
... The GenePix Professional 4200A can be ... GenePix Autoloader automatically loads, scans, analyzes, and ... then notifies you by email when the ... field uniformity, even for warped slides. GenePix ...
... microarray data using Asuragens bioinformatics expertise. We ... to extensive data analysis using the most ... in combination with the Gene Expression Profiling ... ,Normalization and basic statistical analysis including publication ...
... Maximize the value of your ... We offer the support you need ... using the most up to date ... with the Gene Expression Profiling Service ...
... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Material: ...
Biology Products: